Evidence map›Paper›PMID 41848341›Full record

ArticleJournal of virology2026

Respiratory syncytial virus infection induces heterologous protection against SARS-CoV-2 through γδ T cell-mediated trained immunity and the activation of SARS-CoV-2-reactive mucosal T cells.

Awadalkareem Adam, Wenzhe Wu, Madison C Jones, Haiping Hao, Aditi, Parimal Samir, Xiaoyong Bao, Tian Wang

Abstract read
In one paragraph

Article in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Awadalkareem AdamDepartment of Microbiology & Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
Wenzhe WuDepartment of Pediatrics, University of Texas Medical Branch, Galveston, Texas, USA.
Madison C JonesDepartment of Microbiology & Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
Haiping HaoDepartment of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, Texas, USA.
AditiDepartment of Microbiology & Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
Parimal SamirDepartment of Microbiology & Immunology, University of Texas Medical Branch, Galveston, Texas, USA.ORCID 0000-0001-7655-5713
Xiaoyong BaoDepartment of Pediatrics, University of Texas Medical Branch, Galveston, Texas, USA.
Tian WangDepartment of Microbiology & Immunology, University of Texas Medical Branch, Galveston, Texas, USA.ORCID 0000-0002-1511-0793

Funding

Revolutionary Eilat-based Chikungunya Vaccine VectorR01AI127744 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI WANG, TIAN · 2017 to 2021
$3.5M
Role of microglia in neural infectionR01NS125778 · NINDS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI Tian Wang, Ping Wu · 2022 to 2026
$2.5M
tRNA-derived RNA Fragments (tRF) as Prognostic and Diagnostic Biomarkers for Alzheimer’s DiseaseR61AG075725 · NIA · UNIVERSITY OF TEXAS MED BR GALVESTON · PI BAO, XIAOYONG, FANG, XIANG · 2023 to 2025
$2.4M
Gammadelta T cell Regulation of Adaptive Immunity in West Nile Virus InfectionR01AI072060 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI WANG, TIAN · 2008 to 2012
$1.9M
tRNA-derived RNA Fragments and their Role in Nasal SARS-CoV-2 InfectionR21AI166543 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI BAO, XIAOYONG · 2022 to 2023
$680k
Novel Hamster Models of Chikungunya Viral ArthritisR21AI178135 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI WANG, TIAN, WANG, ZHONGDE · 2024 to 2025
$444k
NIAID NIH HHS R01 AI072060NIAID NIH HHS R01 AI127744NIAID NIH HHS R21 AI166543NIAID NIH HHS R21 AI178135NIA NIH HHS R61 AG075725NINDS NIH HHS R01 NS125778
6 · The paper itself

Abstract

Respiratory viruses can infect hosts concurrently or sequentially, potentially influencing each other's pathogenic trajectory. However, the underlying immune mechanisms governing these interactions remain poorly understood. In this study, we examined whether respiratory syncytial virus (RSV) infection modulates host susceptibility to subsequent SARS-CoV-2 infection using two murine models. We found that prior RSV infection conferred dose- and time-dependent heterologous protection against SARS-CoV-2. Transcriptomic and immunological analyses revealed that RSV activated lung antigen-presenting cells (APCs) and SARS-CoV-2-reactive mucosal T cells by day 9 post-infection, with responses waning by 1 month. RSV also promoted expansion of pulmonary γδ T cells and upregulation of their metabolic pathways. Notably, RSV-infected TCRδ⁻

Indexed as

COVID-19Immunity, HeterologousImmunity, MucosalReceptors, Antigen, T-Cell, gamma-deltaRespiratory Syncytial Virus InfectionsSARS-CoV-2T-LymphocytesAnimalsAntigen-Presenting CellsDisease Models, AnimalFemaleLungMiceMice, Inbred C57BLMice, KnockoutRespiratory Syncytial VirusesReceptors, Antigen, T-Cell, gamma-deltaRSVSARS-CoV-2trained immunityγδ T cells

Identifiers

PMID41848341
PMCPMC13002117

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.